WO1998044959A1 - Deodorant - Google Patents

Deodorant Download PDF

Info

Publication number
WO1998044959A1
WO1998044959A1 PCT/JP1997/001167 JP9701167W WO9844959A1 WO 1998044959 A1 WO1998044959 A1 WO 1998044959A1 JP 9701167 W JP9701167 W JP 9701167W WO 9844959 A1 WO9844959 A1 WO 9844959A1
Authority
WO
WIPO (PCT)
Prior art keywords
component
deodorant
dihydroxybenzene
benzoquinone
naphthoquinone
Prior art date
Application number
PCT/JP1997/001167
Other languages
French (fr)
Japanese (ja)
Inventor
Yasuo Fujimoto
Tadashi Imai
Tadao Hamaya
Original Assignee
Ricom Corporation
Ricom Shoji Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricom Corporation, Ricom Shoji Corp. filed Critical Ricom Corporation
Priority to PCT/JP1997/001167 priority Critical patent/WO1998044959A1/en
Priority to AU21788/97A priority patent/AU2178897A/en
Priority to TW086104957A priority patent/TW371630B/en
Publication of WO1998044959A1 publication Critical patent/WO1998044959A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/01Deodorant compositions

Definitions

  • the present invention relates to a deodorant. More specifically, the present invention relates to metabolism in the body of humans and animals, indoors, in cars, refrigerators, toilets, livestock farms, pig farms, poultry farms, fish farms, and other odors.
  • the present invention relates to a deodorant that can effectively remove or reduce malodors and off-odors derived from components having, for example, amines, mercaptans, and fatty acids.
  • pineapple As a deodorant that can effectively remove or reduce bad odors and odors generated in the metabolism of humans and animals, toilets, livestock farms, and other environments, pineapple is water or a hydrophilic solvent.
  • the mushroom extract is a mixture containing many types of components, and no component having a deodorizing effect has been identified. In other words, this extract is expected to contain components that have no deodorizing effect at all, and it is necessary to use a relatively large amount to obtain an effective deodorizing effect.
  • problems such as contamination of the wall surface or precipitation of components that do not have a deodorizing effect, resulting in deterioration of the storage stability of the product.
  • An object of the present invention is to provide a deodorant which does not have such a problem and has an excellent deodorizing effect, particularly, a spatial deodorizing effect.
  • the present invention provides a deodorant containing, as an active ingredient, at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof.
  • the present invention also provides a deodorant containing, as an active ingredient, an extract obtained by extracting an acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water.
  • the present invention provides a deodorant containing, as active ingredients, at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof, and an acidic aqueous extract of mushrooms. It is provided.
  • the present invention also provides an extract obtained by extracting an acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water; and a deodorant containing an acidic aqueous extract of mushrooms as an effective component. Is provided.
  • the present invention further relates to at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof; wherein the acidic aqueous extract of mushrooms is insoluble or slightly soluble in water.
  • the present invention provides a deodorant comprising: an extract obtained by extraction with an organic solvent; and an acidic aqueous extract of mushrooms.
  • At least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof, which is an active ingredient of the deodorant of the present invention (hereinafter, these compounds are referred to as “component A”). ) Will be described.
  • Preferred compounds as the A component of the present invention are 1,4-dihydroxybenzene, 1,4-benzoquinone, 1,4-dihydroxynaphthylene, 1,4-naphthoquinone, 1,2-dihydroxybenzene, and 1,2-bene.
  • R 1 to R 4 are each independently a hydrogen atom, a linear or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon group, and An alkyl group, a carboxyalkyl group, a carboxyalkenyl group, a carboxyl group, an aryl group having 6 to 20 carbon atoms, and R 1 and R 2 are reduced in cooperation with each other.
  • 'It may form a ring.
  • R 5 to R 8 are each independently a hydrogen atom, a linear or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon group, and An alkyl group, a carboxyalkyl group, a carboxyalkenyl group, a carboxyl group, or an aryl group having 6 to 20 carbon atoms, and R 5 and R 6 may together form a condensed benzene ring
  • R 5 and R 6 may together form a condensed benzene ring
  • preferred are 1,4-dihydroxybenzene, 1,4-dihydroxynaphthylene and derivatives thereof, and particularly preferred are the compounds represented by the general formula (3) It is a compound represented by these.
  • the deodorant of the present invention may be composed of only the active ingredient A, but it is used in a form in which a predetermined amount of the ingredient A is contained in foods, oral compositions, pharmaceuticals, feeds, and the like. You can also. Further, the deodorant of the present invention is used in the form of an aerosol composition. You can also. Commercially available A component, which is an active ingredient of the deodorant of the present invention, may be used as it is, but A component obtained by extracting an acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water. (Hereinafter, this extract may be referred to as "component B"). The present inventors have further studied the deodorant active ingredient contained in the mushroom extract, and as a result, have found that the deodorant active ingredient is the A component, and completed the present invention. It is a thing.
  • the component A which is an active ingredient of the deodorant of the present invention, includes known substances. Therefore, a commercially available component A can be used as it is as an active ingredient of the deodorant of the present invention.
  • the extract obtained by extracting the acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water contains a large amount of the A component. This extract may be used as it is, or it may be used after further purification and isolation of component A.
  • a 0.05 to 10% by weight aqueous solution of an acid for example, an organic acid such as malic acid, citric acid, or acetic acid, or an inorganic acid such as hydrochloric acid
  • an acid for example, an organic acid such as malic acid, citric acid, or acetic acid, or an inorganic acid such as hydrochloric acid
  • the acidic water extract (hereinafter sometimes referred to as “component C”) is preferably further concentrated 2 to 50 times, more preferably 10 to 20 times, and then concentrated.
  • an extract (component B) containing a large amount of component A (for example, 2.5 to 25% by weight) can be obtained.
  • Purification by separation and purification means such as chromatography yields pure A component, ie, 1,4-dihydroxybenzene.
  • the present invention relates to an extract (C component) containing a large amount (for example, 0.01 to 5% by weight) of the A component thus obtained, and a further large amount of the A component obtained by purifying the C component. (For example, 2.5 to 25% by weight) containing an extract (B component) or an A component obtained by further refining the B component as an active ingredient.
  • the deodorant of the present invention may be composed of 100% by weight of the component A.
  • the deodorant containing components other than the component A is convenient in use and economically. Is also advantageous.
  • the content of the component A in the deodorant of the present invention in the case of using the component B or the component C, it means the total amount including the component A included in these components.
  • the food containing the deodorant of the present invention is not particularly limited.
  • candy, chewing gum, confectionery, bread, pickles, seasonings, miso, porridge, drinks, jelly, soup, gyoza, health food examples include wine and shochu.
  • the content of the A component in the food is usually from 0.0005 to 50% by weight, preferably from 0.005 to 0.5% by weight, and more preferably from 0.005 to 0.5% by weight. 0.05% by weight.
  • the oral composition containing the deodorant of the present invention is not particularly limited, and examples thereof include toothpaste and mouthwash compositions.
  • the content of the component A in the oral composition is usually from 0.0005 to 50% by weight, preferably from 0.005 to 0.5% by weight, more preferably from 0.5 to 0.5% by weight. It is 0.05 to 0.05% by weight.
  • the drug containing the deodorant of the present invention is not particularly limited, and examples thereof include a gastrointestinal drug, a bimin drug and the like.
  • the content of the component A in the drug is usually 0.0005 to 50% by weight, preferably 0.05 to 0.5% by weight, more preferably 0.05 to 0.5% by weight. ⁇ 0.05% by weight.
  • the feed containing the deodorant of the present invention is not particularly limited. Examples thereof include livestock such as cattle, pigs, horses, and sheep, poultry such as chickens, quail, goose, turkey, duck, ostrich, etc. Animal feed (including fish, etc.) raised in pet animals such as small birds, zoos, aquariums, fish farms, etc., and other animal feeds.
  • the content of the component A in such feed is usually 0.0005 to 50% by weight, preferably 0.005 to 0.5% by weight, and more preferably 0.05 to 0.5% by weight. 0.5-0.05% by weight.
  • the deodorant of the present invention can be used alone as the component A, the component B, a combination of the components A and B, a combination of the components A and C, a combination of the components B and C, A component, B component and C component can also be used in combination.
  • the active ingredient can be used as it is, or can be added to various carriers such as foods, oral compositions, pharmaceuticals, feeds and the like, and used in the form of solids, liquids, powders and the like. Further, it can be used in the form of an aerosol composition.
  • the aerosol composition may contain only the active ingredient of the deodorant of the present invention as an active ingredient, or may contain other components that do not inhibit the deodorant effect of the deodorant of the present invention. .
  • the content of the component A in the aerosol composition is usually from 0.0005 to 5% by weight, preferably from 0.005 to 0.5% by weight, and more preferably from 0.005 to 0.5% by weight. 00.05% by weight.
  • the oral deodorant of the present invention can remove or reduce malodors such as bad odors and bad odors generated by the metabolism of foods or foods by ingesting an appropriate amount orally.
  • Oral ingestion of the deodorant of the present invention may be usually before, during, or after ingestion of food, but is preferably before or ingestion of food.
  • the oral intake varies depending on the degree of bad breath and body odor, and is not particularly limited. However, as the A component, it is usually 0.05 to 5 Omg, preferably 0.05 to 5 mg per day for an adult. . In order to use the deodorant of the present invention for removing or reducing the malodor and off-flavor of the environment, it is preferable to add the deodorant of the present invention to the feed of the target animal.
  • the environment where components with bad odors and off-flavors may be generated (eg, indoors, cars, refrigerators, toilets, livestock farms, pig farms, poultry farms, fish farming) It is also effective to spray the deodorant of the present invention in the field or other places).
  • Application rate varies depending on the degree of bad smell 'off-flavor, usually, per lm 2 or lm 3, 0 as the A component. 0 0 0 5 to 1 0 g, preferably 0.0 0 5 about 1 g is appropriate It is.
  • the deodorant active ingredient of the present invention is the A component in the metabolite of matsushroom, and thus, a deodorant effect can be obtained.
  • hydroquinone of component A is oxidized to benzoquinone, addition of mercapones and adsorption of ammonia and amines occur, and the deodorizing effect is exhibited.
  • the active ingredient A of the present invention is non-toxic or low-toxic.
  • the LD 50 value of 1,4-dihydroxybenzene after oral administration to rats is 32 Omg / kg [Woodard, Fed. Proc. , 8, 348 (1949)].
  • the present invention will be described more specifically with reference to Examples.
  • TLC thin layer chromatography
  • Example 1 25 mg of the A component (1,4-dihydroxybenzene) obtained from 4.69 g of the ethyl acetate extract was diluted 480-fold with purified water, and further diluted with purified water. The deodorizing effect on methyl mercaptan was examined using the liquid diluted 50-fold with the following test method. At the same time, a diluent of a commercially available 1,4-dihydroxybenzene (manufactured by Tokyo Chemical Industry Co., Ltd.) was prepared in the same manner, and its deodorizing effect was similarly examined.
  • 1,4-dihydroxybenzene manufactured by Tokyo Chemical Industry Co., Ltd.
  • Example 1 Using the A component (1,4-dihydroxybenzene), the B component and the C component obtained in Example 1, a chewing gum was produced with the following composition.
  • the numbers indicate the number of g in 100 g of chewing gum.
  • Composition 1 Composition 2 Composition 3 No. Latinit 64.0 64.7 64.7 Gum base 25.0 25.0 25.0
  • Example 1 Using the A component (1,4 dihydroxybenzene), the B component and the C component obtained in Example 1, a candy was produced with the following composition. The number indicates the number of g in 100 g of the candy.
  • Composition 1 Composition 2
  • Composition 3 Granulated sugar 60.0 61.0 61.0
  • Example 1 Using A component (1,4-dihydroxybenzene), B component and C component obtained in Example 1, a drink was produced with the following composition. The number indicates the number of g in 100 g of drink.
  • Composition 1 Composition 2
  • Composition 3 Liquid sugar 10.7 10.7 10.7 Sugar 3.0 3.0 3.0
  • Malic acid 0.1 0.1 0.1 0.1
  • Example 2 Using the A component (1,4-dihydroxybenzene), the B component, and the C component obtained in Example 1, an aerosol composition having the following composition was produced.
  • the numbers indicate the number of g in 100 g of the aerosol composition.
  • Composition 1 Composition 2
  • Composition 3 Ethanol 99.16 99.75 99.75 Ethyl paraben 0.12 0.12 0.12 Propyl paraben 0.06 0.06 0.06 Butyl paraben 0.06 0.06 0.06 A component 0.0000625 B component 0.00125
  • component A, component B, a combination of components A and B, or a combination of component C and component C Can be used, but contains components other than the deodorant active ingredient, does not contain component B or C, especially does not contain component C, that is, contains only component A as an active ingredient are preferred.
  • component C has stickiness and peculiar odor, and when used in aerosols, there is a problem that the odor is worrisome. This is because there is no odor or odor, and the deodorizing effect is also quick.
  • the deodorant of the present invention when used as an oral deodorant for foods, vaginal compositions, pharmaceuticals, feeds, pet foods, etc., A component, B component, a combination of A component and B component, or Can be used in combination with component C, but deodorant includes components other than active components, components containing components C and B, especially those containing component C, that is, a combination of component C and component A
  • deodorant includes components other than active components, components containing components C and B, especially those containing component C, that is, a combination of component C and component A
  • the combination of the C component and the B component, the combination of the C component, the B component and the A component, and the combination of the B component and the A component are preferable.
  • the active ingredient A When used in vivo to remove bad odors such as bad breath, body odor, and fecal odor, the active ingredient A alone may be used.However, in order to obtain the effect of improving diarrhea and constipation, etc. It is better to use C and B components together. That is, when used for the purpose of deodorization in a living body, the C or B component obtained by highly concentrating a mushroom acidic water extract is preferable, and the A solution is added to the concentrated solution (C or B component). By using this, the intestinal deodorization and prevention of diarrhea and constipation, and the improvement of the entire intestinal environment, such as the effect of multiplying useful intestinal bacteria, are achieved.
  • the component contains a component that acts as a certain catalyst to improve the intestinal deodorizing effect in cooperation with the component A.
  • the deodorant of the present invention can be used in combination with a material that has a favorable effect on the intestinal environment, such as oligosaccharides, dietary fiber, and lactic acid bacteria.
  • a material that has a favorable effect on the intestinal environment such as oligosaccharides, dietary fiber, and lactic acid bacteria.
  • the following test examples show test examples conducted using feed that combines component A and component C or component B.
  • aqueous solution obtained by dissolving 200 g of component A (1,4-dihydroxybenzene) and 1.6 kg of dextrin in 2 kg of a concentrate (component C) prepared from 1 O kg of mushrooms according to the method of Example 1 kg, and spray-dried to obtain 2 kg of the feed powder of the present invention.
  • This feed powder was administered to Holstein beef cattle once a day for 10 days at 10 Omg, and the stool odor and stool flatness were observed.
  • Table 3 shows an overview of the test cows. To three test groups, 100 mg of feed powder was dissolved in 500 cc of warm water and administered. Three control groups received only warm water.
  • Fecal odor was evaluated by sensory tests, and the deodorizing effect was evaluated in the following three stages.
  • the condition of the stool was visually observed and evaluated in the following three stages.
  • G male 25 years old
  • H female 26 years old
  • I male 41 years old
  • the fecal odor suppression and intestinal environment were examined for 3 days before the start of ingestion and 11 days after the start, for a total of 14 days.
  • Fecal odor was evaluated by sensory tests, and the deodorizing effect was evaluated in the following three stages.
  • the intestinal environment (constipation, diarrhea, etc.) was evaluated in the following three stages by self-examination by panelists.
  • the deodorant of the present invention contains the A component and / or the B component as an active ingredient, and has a more concentrated active ingredient compared to a conventional deodorant composed of mushroom extract (C component). It can effectively deodorize various foods, especially chewing gum, candy, and other foods that are difficult to ingest in large amounts by simply adding a small amount.
  • the deodorant of the present invention containing only the A component as an active ingredient is an unnecessary component other than the deodorant component, and does not contain a component that causes precipitation peculiar to the matsushroom extract. It can prevent the generation of sediment even when applied to other products, and can be widely used as a variety of products, especially as a space deodorant.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Cosmetics (AREA)

Abstract

A deodorant containing at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone, and derivatives of these compounds as the main component; and foods, oral preparations, drugs and feed containing the same.

Description

明細書 消臭剤  Description Deodorant
〔技術分野〕 〔Technical field〕
本発明は、 消臭剤に関する。 更に詳細には、 本発明は、 ヒトゃ動物の体内での 代謝、 室内、 車内、 冷蔵庫、 トイレ、 畜産牧場、 養豚場、 養鶏場、 養魚場、 その 他の環境で生成される、 悪臭 '異臭を有する成分、 例えばアミン類、 メルカプ夕 ン類、 脂肪酸類等に由来する悪臭 ·異臭を有効に除去ないし低減することができ る消臭剤に関する。  The present invention relates to a deodorant. More specifically, the present invention relates to metabolism in the body of humans and animals, indoors, in cars, refrigerators, toilets, livestock farms, pig farms, poultry farms, fish farms, and other odors. The present invention relates to a deodorant that can effectively remove or reduce malodors and off-odors derived from components having, for example, amines, mercaptans, and fatty acids.
〔従来の技術〕 [Conventional technology]
ヒトゃ動物の体内での代謝、 トイレ、 畜産牧場その他の環境で生成される、 悪 臭 ·異臭を有効に除去ないし低減することができる消臭剤としては、 マツシュル 一ムを水あるいは親水性溶媒で抽出した成分を有効成分とするものがある (特開 平 2— 2 7 7 4 5 6号、 米国特許出願第 0 8 1 0 7 3 3 3号、 ヨーロッパ特許 第 0 3 8 1 0 5 5号) 。 しかしながら、 マッシュルーム抽出物は多種類の成分を 含む混合物であり、 消臭効果を有する成分は特定されていない。 すなわち、 この 抽出物には、 消臭効果を全く持たない成分が混在していることが予想され、 有効 な消臭効果を得るためには、 比較的多量に使用する必要があり、 室内を消臭する ための空間消臭剤として使用すると、 壁面を汚染したり、 あるいは消臭効果を持 たない成分等が沈殿を引き起こして、 製品の保存性を低下する等の問題があった。  As a deodorant that can effectively remove or reduce bad odors and odors generated in the metabolism of humans and animals, toilets, livestock farms, and other environments, pineapple is water or a hydrophilic solvent. (See JP-A-2-2774556, U.S. Patent Application No. 081073333, European Patent No. 03801055) No.) However, the mushroom extract is a mixture containing many types of components, and no component having a deodorizing effect has been identified. In other words, this extract is expected to contain components that have no deodorizing effect at all, and it is necessary to use a relatively large amount to obtain an effective deodorizing effect. When used as a space deodorant for odor, there were problems such as contamination of the wall surface or precipitation of components that do not have a deodorizing effect, resulting in deterioration of the storage stability of the product.
〔発明の開示〕 [Disclosure of the Invention]
本発明の目的は、 このような問題点のない、 消臭効果、 特に空間消臭効果に優 れた消臭剤を提供することである。  An object of the present invention is to provide a deodorant which does not have such a problem and has an excellent deodorizing effect, particularly, a spatial deodorizing effect.
本発明は、 ジヒドロキシベンゼン、 ベンゾキノン、 ジヒドロキシナフタレン、 ナフトキノン及びこれらの誘導体からなる群から選択された少なくとも 1種の化 合物を有効成分として含有する消臭剤を提供するものである。 本発明はまた、 マッシュルームの酸性水抽出液を、 水に不溶あるいは微溶の有 機溶媒で抽出して得られる抽出物を有効成分として含有する消臭剤を提供するも のである。 The present invention provides a deodorant containing, as an active ingredient, at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof. The present invention also provides a deodorant containing, as an active ingredient, an extract obtained by extracting an acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water.
本発明は、 ジヒドロキシベンゼン、 ベンゾキノン、 ジヒドロキシナフタレン、 ナフトキノン及びこれらの誘導体からなる群から選択された少なくとも 1種の化 合物と、 マッシュルームの酸性水抽出液とを有効成分として含有する消臭剤を提 供するものである。  The present invention provides a deodorant containing, as active ingredients, at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof, and an acidic aqueous extract of mushrooms. It is provided.
本発明はまた、 マッシュルームの酸性水抽出液を、 水に不溶あるいは微溶の有 機溶媒で抽出して得られる抽出物と;マッシュルームの酸性水抽出液とを有効成 分として含有する消臭剤を提供するものである。  The present invention also provides an extract obtained by extracting an acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water; and a deodorant containing an acidic aqueous extract of mushrooms as an effective component. Is provided.
本発明はさらにまた、 ジヒドロキシベンゼン、 ベンゾキノン、 ジヒドロキシナ フタレン、 ナフトキノン及びこれらの誘導体からなる群から選択された少なくと も 1種の化合物と;マッシュルームの酸性水抽出液を、 水に不溶あるいは微溶の 有機溶媒で抽出して得られる抽出物と;マッシュルームの酸性水抽出液とを含む 消臭剤を提供するものである。  The present invention further relates to at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof; wherein the acidic aqueous extract of mushrooms is insoluble or slightly soluble in water. The present invention provides a deodorant comprising: an extract obtained by extraction with an organic solvent; and an acidic aqueous extract of mushrooms.
〔発明を実施するための最良の形態〕 [Best mode for carrying out the invention]
本発明の消臭剤の有効成分である、 ジヒドロキシベンゼン、 ベンゾキノン、 ジ ヒドロキシナフタレン、 ナフトキノン及びこれらの誘導体からなる群から選択さ れた少なくとも 1種の化合物 (以下これらの化合物を 「A成分」 と称することも ある。 ) について説明する。  At least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof, which is an active ingredient of the deodorant of the present invention (hereinafter, these compounds are referred to as “component A”). ) Will be described.
本発明の A成分として好ましい化合物は 1 , 4ージヒドロキシベンゼン、 1 , 4一べンゾキノン、 1, 4ージヒドロキシナフ夕レン、 1, 4—ナフトキノン、 1 , 2—ジヒドロキシベンゼン、 1 , 2—べンゾキノン、 1 , 2—ジヒドロキシ ナフタレン、 1 , 2—ナフトキノン及びこれらの誘導体からなる群から選択され たものであり、 さらに好ましくは 1 , 4ージヒドロキシベンゼン、 1 , 4—ベン ゾキノン、 し 4—ジヒドロキシナフ夕レン、 1, 4一ナフトキノンであり、 具 体的には、 以下の一般式 ( 1 ) 又は (2 ) で表されるものが挙げられる。
Figure imgf000005_0001
Preferred compounds as the A component of the present invention are 1,4-dihydroxybenzene, 1,4-benzoquinone, 1,4-dihydroxynaphthylene, 1,4-naphthoquinone, 1,2-dihydroxybenzene, and 1,2-bene. Nzoquinone, 1,2-dihydroxynaphthalene, 1,2-naphthoquinone and derivatives thereof, more preferably 1,4-dihydroxybenzene, 1,4-benzoquinone, and 4-dihydroxy Naphthylene and 1,41-naphthoquinone, specifically, those represented by the following general formula (1) or (2).
Figure imgf000005_0001
(式中、 R1 〜R4 は、 それぞれ独立して、 水素原子、 直鎖又は分岐の、 飽和又 は不飽和の、 置換又は無置換の炭化水素基であり、 例えば、 炭素原子数 1〜1 0 のアルキル基、 カルボキシアルキル基、 カルボキシアルケニル基、 カルボキシル 基、 炭素原子数 6〜20のァリール基である。 また、 R1 及び R2 は協力して縮 (Wherein, R 1 to R 4 are each independently a hydrogen atom, a linear or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon group, and An alkyl group, a carboxyalkyl group, a carboxyalkenyl group, a carboxyl group, an aryl group having 6 to 20 carbon atoms, and R 1 and R 2 are reduced in cooperation with each other.
'環を形成してもよい。 )  'It may form a ring. )
Figure imgf000005_0002
Figure imgf000005_0002
(式中、 R5 〜R8 は、 それぞれ独立して、 水素原子、 直鎖又は分岐の、 飽和又 は不飽和の、 置換又は無置換の炭化水素基であり、 例えば、 炭素原子数 1〜1 0 のアルキル基、 カルボキシアルキル基、 カルボキシアルケニル基、 カルボキシル 基、 炭素原子数 6〜20のァリール基である。 また、 R5 及び R6 は協力して縮 合ベンゼン環を形成してもよい。 ) 一般式 ( 1) で表される化合物のうち、 好ましいものは 1, 4—ジヒドロキシ ベンゼン、 1, 4ージヒドロキシナフ夕レン及びその誘導体であり、 特に好まし いものは一般式 (3) で表される化合物である。
Figure imgf000006_0001
(Wherein, R 5 to R 8 are each independently a hydrogen atom, a linear or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon group, and An alkyl group, a carboxyalkyl group, a carboxyalkenyl group, a carboxyl group, or an aryl group having 6 to 20 carbon atoms, and R 5 and R 6 may together form a condensed benzene ring Among the compounds represented by the general formula (1), preferred are 1,4-dihydroxybenzene, 1,4-dihydroxynaphthylene and derivatives thereof, and particularly preferred are the compounds represented by the general formula (3) It is a compound represented by these.
Figure imgf000006_0001
(R1 〜R4 は上記定義のとおりである。 ) (R 1 to R 4 are as defined above.)
本発明に使用される化合物の具体例を以下に示すが、 本発明はこれらの化合物 に限定されるものではない。  Specific examples of the compounds used in the present invention are shown below, but the present invention is not limited to these compounds.
1 , 4ージヒドロキシベンゼン (ヒドロキノン) 1,4-dihydroxybenzene (hydroquinone)
1, 2—ジヒドロキシベンゼン (カテコール) 1, 2-dihydroxybenzene (catechol)
3, 4—ジヒドロキシ安息香酸 3, 4-dihydroxybenzoic acid
2—メチル一 1, 4ージヒドロキシベンゼン (メチルヒドロキノン)  2-Methyl-1,4-dihydroxybenzene (methylhydroquinone)
2, 5—ジヒドロキシ安息香酸  2,5-dihydroxybenzoic acid
3, 4ージヒドロキシゲイ皮酸 (カフェイン酸)  3,4-dihydroxy gay cinnamate (caffeic acid)
ケルセチン Quercetin
2, 3—ジメチルヒドロキノン  2,3-dimethylhydroquinone
1 , 4一べンゾキノン (P—キノン)  1,4 Benzoquinone (P-quinone)
2, 5—ジヒドロキシー 1, 4一べンゾキノン  2,5-dihydroxy-1,4-benzoquinone
2, 5—ジメチルー 1, 4一べンゾキノン  2,5-dimethyl-1,4-benzquinone
2, 6—ジメチル一 1, 4一べンゾキノン  2,6-Dimethyl-1,4-benzoquinone
3—メチルー 6—イソプロピル一 1, 2—ジヒドロキシベンゼン (タイム抽出物) し 4ージヒドロキンナフタレン  3-Methyl-6-isopropyl-1,2-dihydroxybenzene (thyme extract) and 4-dihydroquinnaphthalene
1, 2—ジヒドロキシナフタレン  1, 2-dihydroxynaphthalene
1, 4—ナフトキノン  1, 4—naphthoquinone
1, 2—ナフトキノン  1, 2-naphthoquinone
本発明の消臭剤は、 有効成分である A成分のみから構成されていてもよレ、が、 食品、 口腔組成物、 医薬品、 飼料等に A成分の所定量を含有させた形態で使用す ることもできる。 また、 本発明の消臭剤は、 エアゾール組成物の形態で使用する こともできる。 本発明の消臭剤の有効成分である A成分は市販品をそのまま使用 してもよいが、 マッシュルームの酸性水抽出液を、 水に不溶あるいは微溶の有機 溶媒で抽出して得られる A成分を主成分として含有する抽出物 (以下この抽出物 を 「B成分」 と称することもある。 ) を使用することもできる。 本発明者等は、 マッシュルーム抽出物中に含まれる消臭有効成分につレ、てさら に検討を進めた結果、 消臭有効成分が A成分であることを見出し、 本発明を完成 するに至ったものである。 The deodorant of the present invention may be composed of only the active ingredient A, but it is used in a form in which a predetermined amount of the ingredient A is contained in foods, oral compositions, pharmaceuticals, feeds, and the like. You can also. Further, the deodorant of the present invention is used in the form of an aerosol composition. You can also. Commercially available A component, which is an active ingredient of the deodorant of the present invention, may be used as it is, but A component obtained by extracting an acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water. (Hereinafter, this extract may be referred to as "component B"). The present inventors have further studied the deodorant active ingredient contained in the mushroom extract, and as a result, have found that the deodorant active ingredient is the A component, and completed the present invention. It is a thing.
本発明の消臭剤の有効成分である A成分には、 公知物質も含まれる。 従って、 本発明の消臭剤の有効成分として市販の A成分をそのまま使用することもできる。 またマッシュルームの酸性水抽出液を、 水に不溶あるいは微溶の有機溶媒 (例え ば、 酢酸ェチルやェチルエーテル等の低沸点有機溶媒) で抽出して得られる抽出 物には多量の A成分が含まれており、 この抽出物をそのまま使用しても良いし、 これを更に精製して、 A成分を単離してから使用しても良い。  The component A, which is an active ingredient of the deodorant of the present invention, includes known substances. Therefore, a commercially available component A can be used as it is as an active ingredient of the deodorant of the present invention. The extract obtained by extracting the acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water (for example, a low-boiling organic solvent such as ethyl acetate or ethyl ether) contains a large amount of the A component. This extract may be used as it is, or it may be used after further purification and isolation of component A.
例えば、 新鮮なマッシュルーム 1 0 0重量部に対して、 酸 (例えば、 リンゴ酸、 クェン酸、 酢酸等の有機酸、 塩酸等の無機酸) の 0 . 0 5〜 1 0重量%水溶液 1 0 0〜5 0 0重量部を加え、 室温ないし約 8 0 °C、 好ましくは 5 0〜7 0 °Cで 1 0分〜 2 4時間抽出する。 この酸性水抽出液 (以下この抽出物を 「C成分」 と称 することもある。 ) を、 好ましくは更に 2〜 5 0倍、 更に好ましくは 1 0〜2 0 倍に濃縮した後、 濃縮物 1 0 0重量部に対して、 水に不溶あるいは微溶の有機溶 媒 1 0〜5 0 0重量部を加え、 5〜4 0 °Cで 1分〜 2 4時間抽出し、 有機層を集 め、 有機溶媒を蒸発させることにより、 A成分を多量に (例えば、 2 . 5〜2 5 重量 含む抽出物 (B成分) が得られる。 この抽出物 (B成分) を、 必要によ りさらにクロマトグラフィ等の分離精製手段により精製すると、 純粋な A成分、 すなわち、 1 , 4ージヒドロキシベンゼンが得られる。  For example, with respect to 100 parts by weight of fresh mushrooms, a 0.05 to 10% by weight aqueous solution of an acid (for example, an organic acid such as malic acid, citric acid, or acetic acid, or an inorganic acid such as hydrochloric acid) is used. Add 〜500 parts by weight, and extract at room temperature to about 80 ° C., preferably 50 to 70 ° C., for 10 minutes to 24 hours. The acidic water extract (hereinafter sometimes referred to as “component C”) is preferably further concentrated 2 to 50 times, more preferably 10 to 20 times, and then concentrated. To 100 parts by weight, add 100 to 500 parts by weight of an organic solvent insoluble or slightly soluble in water, extract at 5 to 40 ° C for 1 minute to 24 hours, and collect the organic layer. Thus, by evaporating the organic solvent, an extract (component B) containing a large amount of component A (for example, 2.5 to 25% by weight) can be obtained. Purification by separation and purification means such as chromatography yields pure A component, ie, 1,4-dihydroxybenzene.
本発明は、 このようにして得られる A成分を多量に (例えば 0 . 0 1〜5重量 %) 含む抽出物 (C成分) や、 C成分を精製して得られる、 A成分をさらに多量 に (例えば 2 . 5〜2 5重量%) 含む抽出物 (B成分) 、 又は B成分をさらに精 製して得られる A成分を有効成分として使用するものである。 本発明の消臭剤は、 上記のとおり、 A成分 1 0 0重量%からなるものであって もよいが、 通常は、 A成分以外の成分を含むものが使用上便利であり、 経済的に も有利である。 本発明の消臭剤中の A成分の含有量 (B成分や C成分を使用する 場合、 これらの成分中に含まれる A成分も含めた合計量を意味する。 以下同様で ある。 ) は、 目的とする悪臭 *異臭の除去ないし低減効果を奏する量であればよ く、 特に限定されないが、 通常は、 0. 0 0 0 0 0 5〜5 0重量%、 好ましくは 0. 0 0 0 5〜0. 5重量%、 さらに好ましくは 0. 0 0 5〜0. 0 5重量%で める。 The present invention relates to an extract (C component) containing a large amount (for example, 0.01 to 5% by weight) of the A component thus obtained, and a further large amount of the A component obtained by purifying the C component. (For example, 2.5 to 25% by weight) containing an extract (B component) or an A component obtained by further refining the B component as an active ingredient. As described above, the deodorant of the present invention may be composed of 100% by weight of the component A. However, usually, the deodorant containing components other than the component A is convenient in use and economically. Is also advantageous. The content of the component A in the deodorant of the present invention (in the case of using the component B or the component C, it means the total amount including the component A included in these components. The same applies to the following.) Target malodor * Any amount is possible as long as it has an effect of removing or reducing off-flavors, and is not particularly limited. Usually, it is 0.000 to 0.005 to 50% by weight, and preferably 0.000 to 0.5% by weight. 00.5% by weight, more preferably 0.005 to 0.05% by weight.
本発明の消臭剤を含有させる食品も特に限定されないが、 例えば、 キャンディ 一、 チューインガム、 菓子、 パン、 漬物、 調味料、 味噌、 お粥、 ドリンク類、 ゼ リー、 スープ、 餃子、 健康食品、 ワイン、 焼酎等が挙げられる。 食品中の A成分 の含有量は、 通常は、 0. 0 0 0 0 0 5〜 5 0重量%、 好ましくは 0. 0 0 0 5 〜0. 5重量 、 さらに好ましくは 0. 0 0 5〜0. 0 5重量%でぁる。  The food containing the deodorant of the present invention is not particularly limited. For example, candy, chewing gum, confectionery, bread, pickles, seasonings, miso, porridge, drinks, jelly, soup, gyoza, health food, Examples include wine and shochu. The content of the A component in the food is usually from 0.0005 to 50% by weight, preferably from 0.005 to 0.5% by weight, and more preferably from 0.005 to 0.5% by weight. 0.05% by weight.
本発明の消臭剤を含有させる口腔組成物も特に限定されないが、 例えば歯磨、 含嗽組成物等が挙げられる。 口腔組成物中の A成分の含有量は、 通常は、 0. 0 0 0 0 0 5〜5 0重量%、 好ましくは 0. 0 0 0 5〜0. 5重量%、 さら に好ましくは 0. 0 0 5〜0. 0 5重量%でぁる。  The oral composition containing the deodorant of the present invention is not particularly limited, and examples thereof include toothpaste and mouthwash compositions. The content of the component A in the oral composition is usually from 0.0005 to 50% by weight, preferably from 0.005 to 0.5% by weight, more preferably from 0.5 to 0.5% by weight. It is 0.05 to 0.05% by weight.
本発明の消臭剤を含有させる医薬品も特に限定されないが、 例えば、 胃腸薬、 ビ夕ミン剤等が挙げられる。 医薬品中の A成分の含有量は、 通常は、 0. 0 0 0 0 0 5~5 0重量%、 好ましくは 0. 0 0 0 5〜0. 5重量%、 さらに好ましく は 0. 0 0 5〜0. 0 5重量%である。  The drug containing the deodorant of the present invention is not particularly limited, and examples thereof include a gastrointestinal drug, a bimin drug and the like. The content of the component A in the drug is usually 0.0005 to 50% by weight, preferably 0.05 to 0.5% by weight, more preferably 0.05 to 0.5% by weight. ~ 0.05% by weight.
本発明の消臭剤を含有させる飼料も特に限定されないが、 例えば、 牛、 豚、 馬、 羊等の家畜類、 鶏、 鶉、 鵞鳥、 七面鳥、 ァヒル、 ダチョウ等の家禽類、 犬、 猫、 小鳥等のぺット動物、 動物園、 水族館、 養魚場等で飼育されている動物 (魚類等 を含む) 、 その他の動物の飼料が挙げられる。 このような飼料中の A成分の含有 量は、 通常、 0. 0 0 0 0 0 5〜5 0重量%、 好ましくは 0. 0 0 0 5〜0. 5 重量%、 さらに好ましくは 0. 0 0 5〜0. 0 5重量%でぁる。  The feed containing the deodorant of the present invention is not particularly limited. Examples thereof include livestock such as cattle, pigs, horses, and sheep, poultry such as chickens, quail, goose, turkey, duck, ostrich, etc. Animal feed (including fish, etc.) raised in pet animals such as small birds, zoos, aquariums, fish farms, etc., and other animal feeds. The content of the component A in such feed is usually 0.0005 to 50% by weight, preferably 0.005 to 0.5% by weight, and more preferably 0.05 to 0.5% by weight. 0.5-0.05% by weight.
また本発明の消臭剤は、 上述のとおり、 A成分、 B成分単独で使用できる他、 A成分と B成分の組合せ、 A成分と C成分の組合せ、 B成分と C成分の組合せ、 A成分と B成分と C成分の組合せで使用することもできる。 As described above, the deodorant of the present invention can be used alone as the component A, the component B, a combination of the components A and B, a combination of the components A and C, a combination of the components B and C, A component, B component and C component can also be used in combination.
また、 上記有効成分は、 そのままの形態で使用できる他、 食品、 口腔組成物、 医薬品、 飼料等の各種担体に添加し、 固体、 液体、 粉末等の形態で使用すること もできる。 さらに、 エアゾール組成物の形態で使用することもできる。  The active ingredient can be used as it is, or can be added to various carriers such as foods, oral compositions, pharmaceuticals, feeds and the like, and used in the form of solids, liquids, powders and the like. Further, it can be used in the form of an aerosol composition.
エアゾール組成物は、 本発明の消臭剤の有効成分のみを有効成分として含むも のであってもよいし、 本発明の消臭剤の消臭効果を阻害しない他の成分を含んで いてもよい。 エアゾール組成物中の A成分の含有量は、 通常、 0 . 0 0 0 0 0 5 〜5重量%、 好ましくは 0 . 0 0 0 5〜0 . 5重量%、 さらに好ましくは 0 . 0 0 5〜0 . 0 5重量%である。  The aerosol composition may contain only the active ingredient of the deodorant of the present invention as an active ingredient, or may contain other components that do not inhibit the deodorant effect of the deodorant of the present invention. . The content of the component A in the aerosol composition is usually from 0.0005 to 5% by weight, preferably from 0.005 to 0.5% by weight, and more preferably from 0.005 to 0.5% by weight. 00.05% by weight.
本発明の消臭剤は、 適量を経口摂取することにより、 食品や食品の代謝により 生成する悪臭 '異臭 (口臭や体臭) を除去ないし低減することができる。  The oral deodorant of the present invention can remove or reduce malodors such as bad odors and bad odors generated by the metabolism of foods or foods by ingesting an appropriate amount orally.
本発明の消臭剤の経口摂取は、 通常は、 食品の摂取の前、 摂取の際、 摂取の後 のいずれでもよいが、 好ましくは食品の摂取の前か、 又は摂取の際が良い。  Oral ingestion of the deodorant of the present invention may be usually before, during, or after ingestion of food, but is preferably before or ingestion of food.
経口摂取量は口臭や体臭の程度によって異なり特に限定されないが、 通常、 A 成分として、 成人 1日当たり 0 . 0 0 5〜5 O mg、 好ましくは 0 . 0 5〜5 mgで あ。。 本発明の消臭剤を、 環境の悪臭 ·異臭の除去又は低減のために使用するには、 対象動物の飼料に本発明の消臭剤を添加しておくことが好ましい。  The oral intake varies depending on the degree of bad breath and body odor, and is not particularly limited. However, as the A component, it is usually 0.05 to 5 Omg, preferably 0.05 to 5 mg per day for an adult. . In order to use the deodorant of the present invention for removing or reducing the malodor and off-flavor of the environment, it is preferable to add the deodorant of the present invention to the feed of the target animal.
また、 悪臭 ·異臭を有する成分 (例えばアミン類、 メルカプ夕ン類、 脂肪酸類 等) が発生するおそれのある環境 (例えば、 室内、 車内、 冷蔵庫、 トイレ、 畜産 牧場、 養豚場、 養鶏場、 養魚場、 その他) に、 本発明の消臭剤を散布しておくこ とも有効である。 散布量は、 悪臭 '異臭の程度によって異なるが、 通常は、 l m2 又は l m3あたり、 A成分として 0 . 0 0 0 5〜1 0 g、 好ましくは 0 . 0 0 5〜 1 g程度が適当である。 In addition, the environment where components with bad odors and off-flavors (eg, amines, mercaps, fatty acids, etc.) may be generated (eg, indoors, cars, refrigerators, toilets, livestock farms, pig farms, poultry farms, fish farming) It is also effective to spray the deodorant of the present invention in the field or other places). Application rate varies depending on the degree of bad smell 'off-flavor, usually, per lm 2 or lm 3, 0 as the A component. 0 0 0 5 to 1 0 g, preferably 0.0 0 5 about 1 g is appropriate It is.
上記のように、 本発明の消臭有効成分はマツシュルームの代謝産物中の A成分 であり、 これにより消臭効果が得られる。 すなわち A成分のヒドロキノンが酸化 されてベンゾキノンになるとメルカプ夕ン類の付加やアンモニア、 ァミン類の吸 着が起こり消臭効果が発現するものと考えられる。 本発明の有効成分である A成分は、 無毒性又は低毒性であり、 例えば、 1, 4 ージヒドロキシベンゼンのラット経口投与による LD50値は、 32 Omg/kgであ る [Woodard, Fed. Proc. , 8, 348 (1949)] 。 以下実施例を示し、 本発明をさらに具体的に説明する。 As described above, the deodorant active ingredient of the present invention is the A component in the metabolite of matsushroom, and thus, a deodorant effect can be obtained. In other words, it is considered that when hydroquinone of component A is oxidized to benzoquinone, addition of mercapones and adsorption of ammonia and amines occur, and the deodorizing effect is exhibited. The active ingredient A of the present invention is non-toxic or low-toxic. For example, the LD 50 value of 1,4-dihydroxybenzene after oral administration to rats is 32 Omg / kg [Woodard, Fed. Proc. , 8, 348 (1949)]. Hereinafter, the present invention will be described more specifically with reference to Examples.
実施例 1 Example 1
新鮮なマッシュルーム 1 0 kgに、 リンゴ酸 1重量%含有する水溶液 20 kgを加 えて、 70°Cで 70分間抽出した。 この抽出物 2 Okgを 1 0倍濃縮して 2 kgの濃 縮液 (C成分) を得た。 この濃縮液を酢酸ェチル 4 kgで分配抽出し、 酢酸ェチル を留去して 4.69 gの抽出物 (B成分) を得た。 この抽出物 (B成分) 中には、 以下に示すように A成分であるヒドロキノン (1, 4—ジヒドロキシベンゼン) が含まれ、 その含有量は 4. 8重量%であった。  To 10 kg of fresh mushrooms, 20 kg of an aqueous solution containing 1% by weight of malic acid was added, and the mixture was extracted at 70 ° C for 70 minutes. 2 kg of this extract was concentrated 10-fold to obtain 2 kg of a concentrated liquid (component C). The concentrated solution was partitioned and extracted with 4 kg of ethyl acetate, and ethyl acetate was distilled off to obtain 4.69 g of an extract (component B). The extract (component B) contained hydroquinone (1,4-dihydroxybenzene) as component A as shown below, and the content was 4.8% by weight.
A成分の同定試験の詳紬を以下に示す。  Details of the A component identification test are shown below.
酢酸ェチル抽出物 (4.69 g) を、 300 gのシリカゲルを充塡したカラムク 口マトグラフィ一に付し、 へキサン :酢酸ェチル = 20 : 1 ( 1 L) , 1 5 : 1 ( 1 L) . 1 0 : 1 ( 1 L) 、 5 : 1 ( 1. 2 L) 、 1 : 1 ( 1 L) 、 酢酸ェチ ル ( 1 L)、 メタノール ( 1 L) で順次溶出し、 70mlづっ試験管に分取した。 分取した各フラクションを薄層クロマトグラフィー (TLC) にてチェックして R f値が近似している物質を含むフラクションをそれぞれ合し、 減圧下濃縮して フラクション A〜Kを得た。 このようにして得たフラクションのうち収量が多か つたフラクション H、 I、 J、 Kについてメチルメル力プ夕ン吸着性を調べたと ころ、 フラクション Ηと Iに強い吸着活性が認められた。 フラクション Iを、 Τ LC (展開溶媒、 へキサン:酢酸ェチル = 1 : 1) にて分析したところ、 R f 0 〜0.4に数個のスポットを示す混合物であったので、 高速液体クロマトグラフィ - (HPLC) により分離'精製を行った。 一方、 フラクション Hは、 TLC及 び H P L Cによりチェックしたところ、 ほぼ純粋な化合物であることが判明した ので、 質量分析 (MS) 及び核磁気共鳴 (NMR) スぺクトルを測定して構造解 析した。 その結果、 この物質はヒドロキノン (1, 4ージヒドロキシベンゼン) であることが判明した。 試験例 1 The ethyl acetate extract (4.69 g) was subjected to column chromatography packed with 300 g of silica gel, and hexane: ethyl acetate = 20: 1 (1 L), 15: 1 (1 L) .1 Elute sequentially with 0: 1 (1 L), 5: 1 (1.2 L), 1: 1 (1 L), ethyl acetate (1 L), and methanol (1 L). I took it out. The fractions collected were checked by thin layer chromatography (TLC), and the fractions containing substances having similar R f values were combined and concentrated under reduced pressure to obtain fractions A to K. Of the fractions obtained in this manner, the fractions H, I, J, and K, which had a high yield, were examined for methyl mercaptan adsorption. The fractions I and I showed strong adsorption activity. Fraction I was analyzed by ΤLC (developing solvent, hexane: ethyl acetate = 1: 1). Since it was a mixture showing several spots at R f 0 to 0.4, high performance liquid chromatography-(HPLC )). On the other hand, the fraction H was checked by TLC and HPLC and found to be an almost pure compound, and its structure was analyzed by measuring mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectrum. . As a result, the substance was found to be hydroquinone (1,4-dihydroxybenzene). Test example 1
実施例 1において、 酢酸ェチル抽出物 4. 6 9 gから得られた A成分 ( 1 , 4一 ジヒドロキシベンゼン) 2 2 5 mgを精製水で 4 8 0倍に希釈し、 これをさらに精 製水で 5 0倍に希釈した液を用いてメチルメルカブタンに対する消臭効果を、 以 下の試験方法により調べた。 同時に市販の 1 , 4ージヒドロキシベンゼン (東京 化成工業 (株) 製) の希釈液も同様の方法で調製し、 その消臭効果を同様に調べ た。 さらに、 実施例 1の C成分を精製水で 5 0倍に希釈した液 8 ml、 実施例 1の B成分を精製水で 2 0 , 0 0 0倍に希釈した液 8 mlについても、 同様にしてその 消臭効果を同様に調べた。  In Example 1, 25 mg of the A component (1,4-dihydroxybenzene) obtained from 4.69 g of the ethyl acetate extract was diluted 480-fold with purified water, and further diluted with purified water. The deodorizing effect on methyl mercaptan was examined using the liquid diluted 50-fold with the following test method. At the same time, a diluent of a commercially available 1,4-dihydroxybenzene (manufactured by Tokyo Chemical Industry Co., Ltd.) was prepared in the same manner, and its deodorizing effect was similarly examined. Furthermore, the same applies to 8 ml of the solution obtained by diluting the component C of Example 1 50 times with purified water and 8 ml of the solution obtained by diluting the component B of Example 1 20 000 times with purified water. The deodorizing effect was similarly examined.
〔試験方法〕  〔Test method〕
1 5 5 mlバイアルビンに、 被験液の ρ Ηを 1 Nの N a〇Hで 7. 2 5に調整した ものを 8 ml入れた。 また対照品として精製水 8 mlを入れた。 バイアルビンにシリ コン栓をし、 アルミニウム製キャップでシールし、 和光純薬工業 (株) 製のメチ ルメル力プ夕ン標準液 (含量: 1 /z g/〃l 、 ベンゼン溶液) を、 メチルメル力 ブタンの初期濃度が 7. 5 p p mとなるように添加した。 夕ツチミキサーで 2 0秒 間攪拌した後、 ガスタイトシリンジで空気を l ml注入し、 混釈後にへッドスべ一 スを l ml抜き取り、 ガスクロマトグラフィーに付した。 ガスクロマトグラムのメ チルメルカプタンのピーク面積を測定し、 メチルメル力プ夕ン濃度 (ppm) を求め た。 攪拌直後、 15分、 30分及び 60分経過後の結果を表 1に示す。  To a 5.5 ml vial bottle, 8 ml of the test solution with ρΗ adjusted to 7.25 with 1N Na〇H was added. As a control, 8 ml of purified water was added. The vial is capped with a silicon stopper, sealed with an aluminum cap, and a methylmer power standard solution (content: 1 / zg / 〃l, benzene solution) manufactured by Wako Pure Chemical Industries, Ltd. Butane was added so that the initial concentration was 7.5 ppm. After stirring for 20 seconds with an evening mixer, 1 ml of air was injected with a gas-tight syringe, and after pulverization, 1 ml of the head base was withdrawn and subjected to gas chromatography. The peak area of methyl mercaptan in the gas chromatogram was measured, and the methyl mercaptan concentration (ppm) was determined. Table 1 shows the results immediately after stirring, and after 15 minutes, 30 minutes and 60 minutes.
表 1 (メチルメルカブタン濃度 (ppm)) 試 料 直後 15分後 30分後 60分後 フラクション A 5. 416 5. 389 5. 091 4. 835 フラクション H 0. 453 0 0 0 フラクション I 2. 811 1. 275 0. 769 0. 273 Table 1 (Methyl mercaptan concentration (ppm)) Sample immediately after 15 minutes 30 minutes after 60 minutes Fraction A 5.416 5.389 5.091 4.835 Fraction H 0.453 0 0 0 Fraction I 2.811 1.275 0.769 0.273
1, 4-ジヒドロキシベンゼン 0. 247 0 0 0 1,4-dihydroxybenzene 0.247 0 0 0
C成分 2. 561 0. 313 0 0 誠分 0. 731 0. 081 0 0 水 6. 123 5. 834 5. 423 4. 107 上記の消臭力試験結果から明らかなように、 水と比較してフラクション H、 フ ラクシヨン I、 及び 1,4-ジヒドロキシベンゼンは優れた消臭効果を有することが ゎカヽる。 Component C 2.561 0.313 0 0 Makoto 0.773 0.081 0 0 Water 6.123 5.834 5.423 4.107 Compared to water, as is clear from the above deodorant power test results. Fraction H Laxion I and 1,4-dihydroxybenzene have excellent deodorizing effects.
試験例 2 Test example 2
1 55mlバイアルビンに、 0. 0 1モル濃度の被験液の pHを 1 Nの Na〇H で 7.25に調整したものを 8 ml入れた。 また対照品として精製水 8 mlを入れた。 バイアルビンにシリコン栓をし、 アルミニウム製キャップでシールし、 和光純薬 工業 (株) 製のメチルメル力プ夕ン標準液 (含量: 1 / μΛ 、 ベンゼン溶液) を、 メチルメルカブタンの初期濃度が 8.5 ppmとなるように添加した。 夕ツチ ミキサーで 20秒間攪拌した後、 ガスタイトシリンジで空気を lml注入し、 混釈 後にヘッドスペースを lml抜き取り、 ガスクロマトグラフィーに付した。 ガスク 口マトグラムのメチルメルカプ夕ンのピーク面積を測定し、 メチルメルカブ夕ン 濃度 (ppm) を求めた。 攪拌直後、 1 5分及び 60分経過後の結果を表 2に示す。  In a 55 ml vial, 8 ml of a 0.01 molar test solution adjusted to pH 7.25 with 1N Na〇H was placed. As a control, 8 ml of purified water was added. The vial is capped with a silicon stopper, sealed with an aluminum cap, and the methylmercaptan standard solution (content: 1 / μΛ, benzene solution) manufactured by Wako Pure Chemical Industries, Ltd. 8.5 ppm was added. After stirring for 20 seconds with a evening mixer, 1 ml of air was injected with a gas-tight syringe, and after pulverization, 1 ml of the headspace was withdrawn and subjected to gas chromatography. The peak area of methyl mercaptan was measured on the gasket matogram, and the methyl mercaptan concentration (ppm) was determined. Table 2 shows the results immediately after stirring, 15 minutes and 60 minutes later.
表 2 (メチルメル力プ夕ン濃度 (ρρπ )  Table 2 (Methylmer force concentration (ρρπ)
試 料 直後 15分後 60分後 Immediately after sample 15 minutes later 60 minutes later
1, 4ージヒドロキシベンゼン 0.00 1,4-dihydroxybenzene 0.00
1. 2—ジヒドロキシベンゼン 2.69 0.00 0.00 3, 4—ジヒドロキシ安息香酸 6.21 3.90 0.57 1.2-dihydroxybenzene 2.69 0.00 0.00 3,4-dihydroxybenzoic acid 6.21 3.90 0.57
2—メチルー 1, 4ージヒドロキシベンゼン 0.00 0.00 0.002-methyl-1,4-dihydroxybenzene 0.00 0.00 0.00
2, 5—ジヒドロキシ安息香酸 3.57 1.21 0.002,5-dihydroxybenzoic acid 3.57 1.21 0.00
3, 4—ジヒドロキシゲイ皮酸 6.10 4.35 1.43 ケルセチン 6.45 4.08 2.703,4-dihydroxygaymic acid 6.10 4.35 1.43 Quercetin 6.45 4.08 2.70
2, 3—ジメチルヒドロキノン 0.16 0.00 2,3-dimethylhydroquinone 0.16 0.00
1, 4—ベンゾキノン 0.00  1,4-benzoquinone 0.00
2, 5—ジヒドロキシ一 1, 4—ベンゾキノン 6.62 5.14 2.44 2, 5—ジメチルー 1, 4—ベンゾキノン 0.56 0.00  2,5-dihydroxy-1,4-benzoquinone 6.62 5.14 2.44 2,5-dimethyl-1,4-benzoquinone 0.56 0.00
2, 6—ジメチル一 1, 4一べンゾキノン 0.26 0.00  2,6-Dimethyl-1,4-benzoquinone 0.26 0.00
1. 3—ジヒドロキシベンゼン 6.04 4.90 3.49 1.3 3-dihydroxybenzene 6.04 4.90 3.49
1, 3, 5—トリヒドロキシベンゼン 6.53 6.08 5.441,3,5-trihydroxybenzene 6.53 6.08 5.44
3-メチル -6-イソブ αビル- 1, 2-ジヒド πキシベンゼン (0.0005モル) 5.60 3.22 0.79 (一) は、 測定しなかったことを意味する < 実施例 2 (チューインガム) 3-Methyl-6-isobu α-bil-1,2-dihydro π-xybenzene (0.0005 mol) 5.60 3.22 0.79 (1) means not measured <Example 2 (chewing gum)
実施例 1で得られた A成分 ( 1 , 4ージヒドロキシベンゼン) 、 B成分及び C 成分を用いて、 下記の組成でチューインガムを製造した。 数字はチューインガム 1 0 0 g中の g数を示す。  Using the A component (1,4-dihydroxybenzene), the B component and the C component obtained in Example 1, a chewing gum was produced with the following composition. The numbers indicate the number of g in 100 g of chewing gum.
組成 1 組成 2 組成 3 ノヽ。ラチニッ卜 64.0 64.7 64.7 ガムベース 25.0 25.0 25.0 Composition 1 Composition 2 Composition 3 No. Latinit 64.0 64.7 64.7 Gum base 25.0 25.0 25.0
70%ソルビトール 5.3 5.3 5.3 グリセリン 5.0 5.0 5.070% sorbitol 5.3 5.3 5.3 Glycerin 5.0 5.0 5.0
A成分 0.0000825A component 0.0000825
B成分 0.00165 B component 0.00165
C成分 0.66 実施例 3 (キャンディ一)  C component 0.66 Example 3 (One candy)
実施例 1で得られた A成分 ( 1 , 4ージヒドロキシベンゼン) 、 B成分及び C 成分を用いて、 下記の組成でキャンディーを製造した。 数字はキャンディー 1 0 0 g中の g数を示す。  Using the A component (1,4 dihydroxybenzene), the B component and the C component obtained in Example 1, a candy was produced with the following composition. The number indicates the number of g in 100 g of the candy.
組成 1 組成 2 組成 3 グラニュー糖 60.0 61.0 61.0 糖アルコール 20.0 20.0 20.0 酸味量 0.5 0.5 0.5 A成分 0.00015 B成分 0.003  Composition 1 Composition 2 Composition 3 Granulated sugar 60.0 61.0 61.0 Sugar alcohol 20.0 20.0 20.0 Acidity 0.5 0.5 0.5 A component 0.00015 B component 0.003
C成分 1.2  C component 1.2
果実系香料 精製水 17.5 17.5 17.5 実施例 4 (ドリンク) Fruit flavors Purified water 17.5 17.5 17.5 Example 4 (drink)
実施例 1で得られた A成分 ( 1, 4ージヒドロキシベンゼン) 、 B成分及び C 成分を用いて、 下記の組成でドリンクを製造した。 数字はドリンク 1 0 0 g中の g数を示す。  Using A component (1,4-dihydroxybenzene), B component and C component obtained in Example 1, a drink was produced with the following composition. The number indicates the number of g in 100 g of drink.
組成 1 組成 2 組成 3 液糖 10.7 10.7 10.7 砂糖 3.0 3.0 3.0 リンゴ酸 0.1 0.1 0.1 香料 0.2 0.2 0.2 A成分 0.000025 B成分 0.0005  Composition 1 Composition 2 Composition 3 Liquid sugar 10.7 10.7 10.7 Sugar 3.0 3.0 3.0 Malic acid 0.1 0.1 0.1 Flavor 0.2 0.2 0.2 A component 0.000025 B component 0.0005
C成分 0.2 C component 0.2
精製水 85.8 86.0 86.0 実施例 5 (エアゾール組成物) Purified water 85.8 86.0 86.0 Example 5 (aerosol composition)
実施例 1で得られた A成分 ( 1, 4ージヒドロキシベンゼン) 、 B成分及び C 成分を用いて、 下記の組成でエアゾール組成物を製造した。 数字はエアゾール組 成物 1 0 0 g中の g数を示す。  Using the A component (1,4-dihydroxybenzene), the B component, and the C component obtained in Example 1, an aerosol composition having the following composition was produced. The numbers indicate the number of g in 100 g of the aerosol composition.
組成 1 組成 2 組成 3 エタノール 99.16 99.75 99.75 ェチルパラベン 0.12 0.12 0.12 プロピルパラベン 0.06 0.06 0.06 ブチルパラベン 0.06 0.06 0.06 A成分 0.0000625 B成分 0.00125  Composition 1 Composition 2 Composition 3 Ethanol 99.16 99.75 99.75 Ethyl paraben 0.12 0.12 0.12 Propyl paraben 0.06 0.06 0.06 Butyl paraben 0.06 0.06 0.06 A component 0.0000625 B component 0.00125
C成分 0.5 本発明の消臭剤を、 エアゾール組成物等の空間消臭剤として用いる場合は、 A 成分、 B成分、 A成分と B成分の組合せ、 又はこれらにさらに C成分を組み合わ せたものを使用することができるが、 消臭有効成分以外の成分を含む B成分又は C成分を含まないもの、 特に C成分を含まないもの、 すなわち、 A成分のみを有 効成分として含有するものが好ましい。 その理由は、 C成分は、 ベとつきや特有 の臭気があり、 エアゾールに用いると、 その臭気が気になる等の問題があるのに 対して、 B成分や A成分では、 このようなべとつきや臭気がなく、 また、 消臭効 果も速効性であるためである。 一方、 本発明の消臭剤を、 食品、 口膣組成物、 医薬品、 飼料、 ペットフード等 の経口消臭剤として用いる場合は、 A成分、 B成分、 A成分と B成分の組合せ、 又はこれらにさらに C成分を組み合わせたものを使用することができるが、 消臭 有効成分以外の成分を含む C成分や B成分を含むもの、 特に C成分を含むもの、 すなわち、 C成分と A成分の組合せ、 C成分と B成分の組合せ、 C成分と B成分 と A成分の組合せ、 B成分と A成分の組合せが好ましい。 Component 0.5 When the deodorant of the present invention is used as a space deodorant for an aerosol composition or the like, component A, component B, a combination of components A and B, or a combination of component C and component C Can be used, but contains components other than the deodorant active ingredient, does not contain component B or C, especially does not contain component C, that is, contains only component A as an active ingredient Are preferred. The reason is that component C has stickiness and peculiar odor, and when used in aerosols, there is a problem that the odor is worrisome. This is because there is no odor or odor, and the deodorizing effect is also quick. On the other hand, when the deodorant of the present invention is used as an oral deodorant for foods, vaginal compositions, pharmaceuticals, feeds, pet foods, etc., A component, B component, a combination of A component and B component, or Can be used in combination with component C, but deodorant includes components other than active components, components containing components C and B, especially those containing component C, that is, a combination of component C and component A The combination of the C component and the B component, the combination of the C component, the B component and the A component, and the combination of the B component and the A component are preferable.
経口摂取して生体内で、 口臭、 体臭、 便臭などの悪臭を除去する目的で用いる 場合は、 有効成分である A成分のみでも良いが、 下痢や便秘等の改善効果を得る ためには、 C成分や B成分を併用した方がよい。 すなわち、 生体内消臭の目的で 用いる場合は、 マッシュルーム酸性水抽出液を高度に濃縮した C成分又は B成分 が好ましく、 また、 その濃縮液 (C成分又は B成分) に A成分を添加したものを 用いることによって、 腸内消臭と下痢や便秘の予防、 腸内有用菌の増殖効果等、 腸内環境全体の改善が達成されるのである。  When used in vivo to remove bad odors such as bad breath, body odor, and fecal odor, the active ingredient A alone may be used.However, in order to obtain the effect of improving diarrhea and constipation, etc. It is better to use C and B components together. That is, when used for the purpose of deodorization in a living body, the C or B component obtained by highly concentrating a mushroom acidic water extract is preferable, and the A solution is added to the concentrated solution (C or B component). By using this, the intestinal deodorization and prevention of diarrhea and constipation, and the improvement of the entire intestinal environment, such as the effect of multiplying useful intestinal bacteria, are achieved.
消臭有効成分以外の成分を含む C成分や B成分を含むもの、 特に C成分を含む ものが経口消臭剤の有効成分として好ましい理由は未だ解明されていないが、 マ ッシュルーム酸性水抽出液の成分の中に、 A成分と共同してその腸内消臭効果を 向上させる、 ある種の触媒の働きをする成分が含有されていることを示唆するも のである。  It is not yet clear why those containing C and B, including those other than the deodorant active ingredient, and especially those containing C are preferred as the active ingredient in oral deodorants. It suggests that the component contains a component that acts as a certain catalyst to improve the intestinal deodorizing effect in cooperation with the component A.
本発明の消臭剤は、 例えばオリゴ糖、 食物繊維、 乳酸菌など腸内環境に良い影 響を与える素材と併用することもできる。 以下の試験例は、 A成分に C成分又は B成分を組合せた飼料を用いて行った試 験例を示すものである。 The deodorant of the present invention can be used in combination with a material that has a favorable effect on the intestinal environment, such as oligosaccharides, dietary fiber, and lactic acid bacteria. The following test examples show test examples conducted using feed that combines component A and component C or component B.
試験例 3 Test example 3
実施例 1の方法に従ってマッシュルーム 1 O kgから製造した 2 kgの濃縮液 (C 成分) に、 A成分 (1, 4ージヒドロキシベンゼン) 2 0 0 gとデキストリン 1. 6 kgを溶解させた水溶液 3 kgを加え、 スプレードライ加工し、 本発明の飼料粉末 2 kgを得た。  An aqueous solution obtained by dissolving 200 g of component A (1,4-dihydroxybenzene) and 1.6 kg of dextrin in 2 kg of a concentrate (component C) prepared from 1 O kg of mushrooms according to the method of Example 1 kg, and spray-dried to obtain 2 kg of the feed powder of the present invention.
ホルスタイン種子牛にこの飼料粉末を、 1日に 1回、 1 0 O mgを 1 4日間投与 して、 便臭及び便の伏態を観察した。  This feed powder was administered to Holstein beef cattle once a day for 10 days at 10 Omg, and the stool odor and stool flatness were observed.
供試牛の概要を表 3に示した。 試験区 3頭には飼料粉末 1 0 O mgを微温湯 5 0 0 ccに溶解して投与した。 対照区 3頭には微温湯のみを投与した。  Table 3 shows an overview of the test cows. To three test groups, 100 mg of feed powder was dissolved in 500 cc of warm water and administered. Three control groups received only warm water.
便臭は官能検査により行レ、、 消臭効果は次の 3段階で評価した。  Fecal odor was evaluated by sensory tests, and the deodorizing effect was evaluated in the following three stages.
1 :便臭弱い  1: Stool odor is weak
2 :便臭中程度  2: Moderate stool odor
3 :便臭強い  3: Strong odor
便の状態は目視で観察し、 評価は次の 3段階で評価した。  The condition of the stool was visually observed and evaluated in the following three stages.
〇:正常  〇: Normal
Δ:泥伏軟便  Δ: Mud soft stool
X :水様性下痢  X: Watery diarrhea
結果を表 4及び表 5に示す。  The results are shown in Tables 4 and 5.
表 3 供試牛の概要 区分 牛番 性別 曰齢 投与日数 摘 要 Table 3 Summary of test cattle Category Cattle gender Gender Name Age Administration days Remarks
試験区 1 平 8 1 4 粉末を 1回当たり lOOmg投与 Test plot 1 flat 8 1 4 Powder administered lOOmg per dose
3頭 2 罕 8 1 4 3 heads 2 hara 8 1 4
3 9 1 4  3 9 1 4
対照区 4 平 7 無投与  Control group 4 flat 7 No administration
3頭 5 罕 7  3 heads 5
6 1 4 表 4 6 1 4 Table 4
便 臭  Stool smell
Figure imgf000017_0001
表 5
Figure imgf000017_0001
Table 5
便の状態  Flight status
Figure imgf000017_0002
試験例 4〜 7
Figure imgf000017_0002
Test examples 4 to 7
以下に示す 9名のパネラー A〜Iに、 以下に示す消臭剤①、 ②、 ③、 ④を単独 で又は組み合わせ、 5 0mlの水に溶解したものを経口摂取させた。  Nine panelists A to I shown below were orally ingested the following deodorants (1), (2), (3), and (4), alone or in combination, dissolved in 50 ml of water.
A:男 4 6才、 B:男 35才、 C:女 28才、  A: Male 46, B: Male 35, C: Female 28,
D:女 3 1才、 E:男 25才、 F:女 4 8才、  D: Female 31 years old, E: Male 25 years old, F: Female 48 years old,
G :男 25才、 H :女 26才、 I :男 4 1才  G: male 25 years old, H: female 26 years old, I: male 41 years old
摂取開始前 3日間、 開始後 1 1日間、 合計 1 4日間、 便臭の抑制及び腸内環境 (便秘 ·下痢などの有無) を調べた。  The fecal odor suppression and intestinal environment (presence of constipation, diarrhea, etc.) were examined for 3 days before the start of ingestion and 11 days after the start, for a total of 14 days.
① 実施例 1で調製された C成分 1 g ( 1 g中の 1, 4—ジヒドロキシベンゼン の量は約 0. 5mg) ② 実施例 1で調製された B成分 1 Omg ( 1 Omg中の 1, 4—ジヒドロキシベン ゼンの量は約 0. 5 rag) ① 1 g of C component prepared in Example 1 (the amount of 1,4-dihydroxybenzene in 1 g is about 0.5 mg) ② 1 Omg of B component prepared in Example 1 (the amount of 1,4-dihydroxybenzene in 1 Omg is about 0.5 rag)
③ 1, 4—ジヒドロキシベンゼン 0. 5mg  ③ 1,4-dihydroxybenzene 0.5mg
④ 1, 4—ジヒド πキシベンゼン 5mg  ④ 1,4-dihydro π-xybenzene 5mg
便臭は官能検査により行レ、、 消臭効果は次の 3段階で評価した。  Fecal odor was evaluated by sensory tests, and the deodorizing effect was evaluated in the following three stages.
1 :便臭弱い  1: Stool odor is weak
2 :便臭中程度  2: Moderate stool odor
3 :便臭強い  3: Strong odor
腸内環境 (便秘 ·下痢などの状態) は、 パネラーの自己検査により、 次の 3段 階で評価した。  The intestinal environment (constipation, diarrhea, etc.) was evaluated in the following three stages by self-examination by panelists.
〇:正常  〇: Normal
Δ:やや良い  Δ: Somewhat good
X :悪い (便秘 ·下痢症) 試験例、 パネラー、 使用した消臭剤、 結果を示す表は以下のとおりである。 試験例 パネラー 消臭剤 結果を示す表  X: Bad (constipation and diarrhea) The test examples, panelists, deodorants used, and the results are shown in the table below. Test example Paneler Deodorant Table showing results
4 A〜I ①、 ③、 ④ 表 6及び表 7  4 A to I ①, ③, ④ Table 6 and Table 7
5 A〜F ② +③、 ② +④ 表 8及び表 9  5 A to F ② + ③, ② + ④ Table 8 and Table 9
6 A〜F ①、 ② 表 1 0及び表 1 1 6 A to F ①, ② Table 10 and Table 11
ϋ V ο υ υ ϋ V 〇 〇 〇 〇 X V 〇 1 ϋ V ο υ υ ϋ V 〇 〇 〇 〇 X V 〇 1
U V υ ο (J リ V V ϋ V V V V Η ® U V υ ο (J V V V ϋ V V V V Η ®
Ό V V V V ϋ 〇 ϋ V V ϋ Ο V 0 ϋ ϋ V V V 〇 〇 〇 V V 〇 V X 〇 Ό V V V V ϋ 〇 ϋ V V ϋ Ο V 0 ϋ ϋ V V V 〇 〇 〇 V V 〇 V X 〇
V V 〇 V 〇 〇 〇 〇 〇 V X X 〇 V d V V 〇 V 〇 〇 〇 〇 〇 V X X 〇 V d
〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 V V 〇 〇 α〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 V V 〇 〇 α
〇 〇 〇 V 〇 〇 〇 〇 〇 V V X V X 0〇 〇 〇 V 〇 〇 〇 〇 〇 V V X V X 0
〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 V V V 〇 a ①V 〇 〇 〇 〇 〇 〇 〇 〇 〇 V V V 〇 a ①
〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 V 〇 〇 V 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 V 〇 〇 V
Τ ΐ Οΐ 6 8 ι 9 9 8 ζ a s ΐ - Τ ΐ Οΐ 6 8 ι 9 9 8 ζ a s ΐ-
¾ ¾? ^ ¾ ¾ ¾? ^ ¾
Figure imgf000019_0001
Figure imgf000019_0001
 暂
9拏 9 Halla
L9ll0/L6d£/13d 表 8 L9ll0 / L6d £ / 13d Table 8
便 臭  Stool smell
Figure imgf000020_0001
表 9
Figure imgf000020_0001
Table 9
腸内環境  Intestinal environment
投 与 前 投 与 後  Before administration After administration
パネラ- 1 曰目 2 3 4 5 6 7 8 9 10 11 12 13 14 Panera-1 statement 2 3 4 5 6 7 8 9 10 11 12 13 14
A Δ 〇 Δ 〇 〇 〇 Δ 〇 〇 〇 Δ 〇 〇 〇A Δ 〇 Δ 〇 〇 〇 Δ 〇 〇 〇 Δ 〇 〇 〇
② +③ B 〇 〇 〇 〇 〇 〇 〇 〇 〇 Δ 〇 〇 〇 〇 ② + ③ B 〇 〇 〇 〇 〇 〇 〇 〇 〇 Δ 〇 〇 〇 〇
C X X Δ Δ 〇 〇 Δ 〇 〇 〇 〇 〇 〇 〇 C X X Δ Δ 〇 〇 Δ 〇 〇 〇 〇 〇 〇 〇
D Δ 〇 〇 Δ 〇 〇 〇 〇 〇 〇 〇 △ 〇 〇D Δ 〇 〇 Δ 〇 〇 〇 〇 〇 〇 〇 △ 〇 〇
② +④ E X Δ X Δ 〇 Δ Δ Δ 〇 〇 〇 〇 〇 〇 ② + ④ E X Δ X Δ 〇 Δ Δ Δ 〇 〇 〇 〇 〇 〇
F Δ 〇 Δ Δ 〇 〇 〇 〇 〇 Δ 〇 〇 〇 〇 F Δ 〇 Δ Δ 〇 〇 〇 〇 〇 Δ 〇 〇 〇 〇
表 1 0 Table 10
便 臭  Stool smell
Figure imgf000021_0001
表 1 1
Figure imgf000021_0001
Table 11
腸内環境  Intestinal environment
Figure imgf000021_0002
試験例 7
Figure imgf000021_0002
Test example 7
6名のパネラー (A〜F) に、 以下に示す消臭剤①、 ②、 ③、 ④を以下のよう に組合せ、 5 0mlの水に溶解したものを経口摂取させた。  Six panelists (A to F) combined the following deodorants (1), (2), (3), and (4) as follows, and orally ingested those dissolved in 50 ml of water.
試験例 4〜6と同様に、 摂取開始前 3日間、 開始後 1 1日間、 合計 1 4日間、 便臭の抑制及び腸内環境(便秘 ·下痢などの有無) を調べた。  As in Test Examples 4 to 6, suppression of fecal odor and intestinal environment (presence or absence of constipation, diarrhea, etc.) were examined for 3 days before the start of ingestion and 11 days after the start, for a total of 14 days.
① 実施例 1で調製された C成分 0. 5 g (0. 5 g中の 1, 4ージヒドロキシ ベンゼンの量は約 0. 25 mg) ② 実施例 1で調製された B成分 2. 5mg (2. 5mg中の 1 4ージヒドロキシ ベンゼンの量は約 0. 1 25mg) ① 0.5 g of C component prepared in Example 1 (the amount of 1,4-dihydroxybenzene in 0.5 g is about 0.25 mg) (2) 2.5 mg of B component prepared in Example 1 (the amount of 14-dihydroxybenzene in 2.5 mg is about 0.125 mg)
③ 1, 4—ジヒドロキシベンゼン 0. 1 25mg  ③ 1,4-dihydroxybenzene 0.1 25mg
④ 1, 4ージヒドロキシベンゼン 4. 5mg  ④ 4.5 mg 1,4-dihydroxybenzene
結果を表 1 2及び表 1 3に示す。 表 1 2  The results are shown in Tables 12 and 13. Table 1 2
便臭  Feces smell
Figure imgf000022_0001
表 1 3
Figure imgf000022_0001
Table 13
腸内環境  Intestinal environment
投 与 前 投 与 後  Before administration After administration
消臭剤 パネラ- 1曰 2 3 4 5 6 7 8 9 10 11 12 13 14  Deodorant Panera-1 says 2 3 4 5 6 7 8 9 10 11 12 13 14
A Δ 〇 Δ Δ Δ 〇 〇 〇 〇 〇 〇 〇 〇 〇 A Δ 〇 Δ Δ Δ 〇 〇 〇 〇 〇 〇 〇 〇 〇
① +② ① + ②
B Δ X X Δ 〇 〇 Δ 〇 〇 〇 〇 〇 〇 〇 +③  B Δ X X Δ 〇 〇 Δ 〇 〇 〇 〇 〇 〇 〇 + ③
C 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 C 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇
D Δ X X Δ 〇 Δ Δ 〇 〇 〇 〇 〇 〇 〇D Δ X X Δ 〇 Δ Δ 〇 〇 〇 〇 〇 〇 〇
① +② ① + ②
E 〇 〇 Δ 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 +④  E 〇 〇 Δ 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 〇 + ④
F Δ Δ Δ Δ 〇 厶 〇 〇 〇 〇 Δ 〇 〇 〇 〔産業上の利用可能性〕 F Δ Δ Δ Δ 厶 〇 〇 〇 〇 〇 Δ 〇 〇 〇 [Industrial applicability]
本発明の消臭剤は、 A成分及び ^ /又は B成分を有効成分として含有するもので あり、 従来のマッシュルーム抽出物 (C成分) からなる消臭剤と比較して、 有効 成分が濃縮されており、 種々の食品、 特にチューインガム、 キャンディ一等、 多 量の摂取が困難である食品に微量添加するだけで消臭効果を有効に発揮する。 また、 A成分のみを有効成分として含有する本発明の消臭剤は、 消臭成分以外 の不要な成分であって、 マツシュルーム抽出物に特有の沈殿の原因となる成分を 含んでいないので、 液体の製品に応用した場合にも、 沈殿物の発生を防ぐことが でき、 多様な製品、 特に空間消臭剤として、 広く使用することができる。  The deodorant of the present invention contains the A component and / or the B component as an active ingredient, and has a more concentrated active ingredient compared to a conventional deodorant composed of mushroom extract (C component). It can effectively deodorize various foods, especially chewing gum, candy, and other foods that are difficult to ingest in large amounts by simply adding a small amount. In addition, the deodorant of the present invention containing only the A component as an active ingredient is an unnecessary component other than the deodorant component, and does not contain a component that causes precipitation peculiar to the matsushroom extract. It can prevent the generation of sediment even when applied to other products, and can be widely used as a variety of products, especially as a space deodorant.

Claims

請求の範囲 The scope of the claims
1 . ジヒドロキシベンゼン、 ベンゾキノン、 ジヒドロキシナフタレン、 ナフトキ ノン及びこれらの誘導体からなる群から選択された少なくとも 1種の化合物を 有効成分として含有する消臭剤。  1. A deodorant containing, as an active ingredient, at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone, and derivatives thereof.
2 . マッシュルームの酸性水抽出液を、 水に不溶あるいは微溶の有機溶媒で抽出 して得られる抽出物を有効成分として含有する消臭剤。  2. A deodorant containing, as an active ingredient, an extract obtained by extracting an acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water.
3 . 更にマッシュルームの酸性水抽出液を含む請求項 1又は 2記載の消臭剤。 3. The deodorant according to claim 1, further comprising an acidic aqueous extract of mushrooms.
4 . ジヒドロキンベンゼン、 ベンゾキノン、 ジヒドロキシナフタレン、 ナフトキ ノン及びこれらの誘導体からなる群から選択された少なくとも 1種の化合物と; マッシュルームの酸性水抽出液を、 水に不溶ぁるいは微溶の有機溶媒で抽出し て得られる抽出物と;マッシュルームの酸性水抽出液とを含む消臭剤。 4. At least one compound selected from the group consisting of dihydroquinbenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof; and an acidic aqueous extract of mushrooms in an insoluble or slightly soluble organic solvent in water. A deodorant comprising: an extract obtained by extraction with; and an acidic aqueous extract of mushrooms.
5 . ジヒドロキシベンゼン、 ベンゾキノン、 ジヒドロキシナフタレン、 ナフトキ ノン及びこれらの誘導体からなる群から選択された少なくとも 1種の化合物が、 以下の一般式 (1 ) 又は (2 ) で表されるものである請求項 1〜4のいずれか 1項記載の消臭剤。  5. At least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone, and derivatives thereof, is represented by the following general formula (1) or (2). 5. The deodorant according to any one of 1 to 4.
Figure imgf000024_0001
Figure imgf000024_0001
(式中、 R 1 〜R 4 は、 それぞれ独立して、 水素原子、 直鎖又は分岐の、 飽和 又は不飽和の、 置換又は無置換の炭化水素基である。 また、 R 1 及び R 2 は協 力して縮合ベンゼン環を形成してもよい。 ) (Wherein, R 1 to R 4 are each independently a hydrogen atom, a linear or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon group. Also, R 1 and R 2 are The fused benzene ring may be formed in cooperation.)
Figure imgf000024_0002
(式中、 R5 〜R8 は、 それぞれ独立して、 水素原子、 直鎖又は分岐の、 飽和又 は不飽和の、 置換又は無置換の炭化水素基である。 また、 R5 及び R6 は協力し て縮合ベンゼン環を形成してもよい。 )
Figure imgf000024_0002
(Wherein, R 5 to R 8 are each independently a hydrogen atom, a linear or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon group. Further, R 5 and R 6 May cooperate to form a fused benzene ring.)
6. ジヒドロキシベンゼン、 ベンゾキノン、 ジヒドロキシナフタレン、 ナフトキ ノン及びこれらの誘導体からなる群から選択された少なくとも 1種の化合物が、 以下の一般式 ( 3 ) で表されるものである請求項 1〜4のいずれか 1項記載の 消臭剤。 6. The method according to claim 1, wherein at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof is represented by the following general formula (3). The deodorant according to any one of the preceding claims.
Figure imgf000025_0001
Figure imgf000025_0001
(式中、 R1 〜R4 は、 それぞれ独立して、 水素原子、 直鎖又は分岐の、 飽和又 は不飽和の、 置換又は無置換の炭化水素基である。 また、 R1 及び R2 は協力し て縮合ベンゼン環を形成してもよい。 ) (Wherein, R 1 to R 4 are each independently a hydrogen atom, a linear or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon group. Further, R 1 and R 2 May cooperate to form a fused benzene ring.)
. ジヒドロキシベンゼン、 ベンゾキノン、 ジヒドロキシナフタレン、 ナフトキ ノン及びこれらの誘導体からなる群から選択された少なくとも 1種の化合物が、 以下の化合物群から選択されたものである請求項 1〜4のいずれか 1項記載の 消臭剤。  The at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone, and derivatives thereof, wherein the compound is selected from the following compound group. The deodorant described.
1, 4ージヒドロキシベンゼン、 1, 2—ジヒドロキシベンゼン、 3, 4—ジヒ ドロキシ安息香酸、 2—メチル— 1, 4ージヒドロキシベンゼン、 2, 5—ジヒ ドロキシ安息香酸、 3, 4—ジヒドロキシゲイ皮酸、 ケルセチン、 2, 3—ジメ チルヒドロキノン、 1, 4一べンゾキノン、 2, 5—ジヒドロキシ一 1, 4—ベ ンゾキノン、 2, 5—ジメチルー 1, 4一べンゾキノン、 2, 6—ジメチルーし 4—ベンゾキノン、 3—メチルー 6—イソプロピル一 1 , 2—ジヒドロキシベン ゼン、 1 , 4—ジヒドロキシナフタレン、 1 , 2—ジヒドロキシナフタレン、 1 , 4—ナフトキノン及び 1, 2—ナフトキノン。 1,4-dihydroxybenzene, 1,2-dihydroxybenzene, 3,4-dihydroxybenzoic acid, 2-methyl-1,4-dihydroxybenzene, 2,5-dihydroxybenzoic acid, 3,4-dihydroxy gay skin Acid, quercetin, 2,3-dimethylhydroquinone, 1,4-benzoquinone, 2,5-dihydroxy-1,4-benzoquinone, 2,5-dimethyl-1,4-benzoquinone, 2,6-dimethyl 4-benzoquinone, 3-methyl-6-isopropyl-1,2-dihydroxybenzene, 1,4-dihydroxynaphthalene, 1,2-dihydroxynaphthalene, 1,4-naphthoquinone and 1,2-naphthoquinone.
8 . 食品の形態にある請求項 1〜 7のいずれか 1項記載の消臭剤。 8. The deodorant according to any one of claims 1 to 7, which is in the form of a food.
9 . 口腔組成物の形態にある請求項 1〜 7のいずれか 1項記載の消臭剤。  9. The deodorant according to any one of claims 1 to 7, which is in the form of an oral composition.
10. 医薬品の形態にある請求項 1〜 7のいずれか 1項記載の消臭剤。  10. The deodorant according to any one of claims 1 to 7, which is in the form of a medicament.
11. 飼料の形態にある請求項 1〜 7のいずれか 1項記載の消臭剤。  11. The deodorant according to any one of claims 1 to 7, which is in the form of a feed.
12. ぺットフードの形態にある請求項 1〜7のいずれか 1項記載の消臭剤。 12. The deodorant according to any one of claims 1 to 7, which is in the form of a pet food.
13. エアゾール組成物の形態にある請求項 1〜 7のいずれか 1項記載の消臭剤。 13. The deodorant according to any one of claims 1 to 7, which is in the form of an aerosol composition.
PCT/JP1997/001167 1997-04-04 1997-04-04 Deodorant WO1998044959A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/JP1997/001167 WO1998044959A1 (en) 1997-04-04 1997-04-04 Deodorant
AU21788/97A AU2178897A (en) 1997-04-04 1997-04-04 Deodorant
TW086104957A TW371630B (en) 1997-04-04 1997-04-17 Deodorizer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1997/001167 WO1998044959A1 (en) 1997-04-04 1997-04-04 Deodorant

Publications (1)

Publication Number Publication Date
WO1998044959A1 true WO1998044959A1 (en) 1998-10-15

Family

ID=14180360

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1997/001167 WO1998044959A1 (en) 1997-04-04 1997-04-04 Deodorant

Country Status (3)

Country Link
AU (1) AU2178897A (en)
TW (1) TW371630B (en)
WO (1) WO1998044959A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047045A1 (en) * 1999-02-13 2000-08-17 Zylepsis Limited Preservative compounds and compositions
JP2009161502A (en) * 2008-01-10 2009-07-23 Rikomu:Kk Agent for ameliorating intestinal flora and food
WO2013083585A1 (en) 2011-12-06 2013-06-13 Unilever N.V. Antimicrobial composition
WO2013092427A2 (en) 2011-12-22 2013-06-27 Unilever N.V. Antimicrobial method and composition
US8945596B2 (en) 2008-10-20 2015-02-03 Conopco, Inc. Antimicrobial composition
US9132103B2 (en) 2009-09-24 2015-09-15 Conopco, Inc. Disinfecting agent comprising eugenol, terpineol and thymol
US9408870B2 (en) 2010-12-07 2016-08-09 Conopco, Inc. Oral care composition
US9693941B2 (en) 2011-11-03 2017-07-04 Conopco, Inc. Liquid personal wash composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4833035A (en) * 1971-08-27 1973-05-07
JPS5036649A (en) * 1973-08-06 1975-04-05
JPS6368172A (en) * 1986-09-11 1988-03-28 松下電工株式会社 Deodorant
JPS6434368A (en) * 1987-07-31 1989-02-03 Lion Corp Deodorant
JPH01317443A (en) * 1988-06-16 1989-12-22 Nippon Zeon Co Ltd Deodorant composition
JPH02277456A (en) * 1989-01-25 1990-11-14 Rikomu:Kk Deodorant
JPH0538358A (en) * 1991-08-07 1993-02-19 Rikomu:Kk Deodorant

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4833035A (en) * 1971-08-27 1973-05-07
JPS5036649A (en) * 1973-08-06 1975-04-05
JPS6368172A (en) * 1986-09-11 1988-03-28 松下電工株式会社 Deodorant
JPS6434368A (en) * 1987-07-31 1989-02-03 Lion Corp Deodorant
JPH01317443A (en) * 1988-06-16 1989-12-22 Nippon Zeon Co Ltd Deodorant composition
JPH02277456A (en) * 1989-01-25 1990-11-14 Rikomu:Kk Deodorant
JPH0538358A (en) * 1991-08-07 1993-02-19 Rikomu:Kk Deodorant

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047045A1 (en) * 1999-02-13 2000-08-17 Zylepsis Limited Preservative compounds and compositions
JP2009161502A (en) * 2008-01-10 2009-07-23 Rikomu:Kk Agent for ameliorating intestinal flora and food
US8945596B2 (en) 2008-10-20 2015-02-03 Conopco, Inc. Antimicrobial composition
US9132103B2 (en) 2009-09-24 2015-09-15 Conopco, Inc. Disinfecting agent comprising eugenol, terpineol and thymol
US9408870B2 (en) 2010-12-07 2016-08-09 Conopco, Inc. Oral care composition
US9693941B2 (en) 2011-11-03 2017-07-04 Conopco, Inc. Liquid personal wash composition
WO2013083585A1 (en) 2011-12-06 2013-06-13 Unilever N.V. Antimicrobial composition
WO2013092427A2 (en) 2011-12-22 2013-06-27 Unilever N.V. Antimicrobial method and composition
WO2013092427A3 (en) * 2011-12-22 2013-08-15 Unilever N.V. Antimicrobial composition comprising isopropyl-methyl catechols

Also Published As

Publication number Publication date
AU2178897A (en) 1998-10-30
TW371630B (en) 1999-10-11

Similar Documents

Publication Publication Date Title
Hoskins The occurrence, metabolism and toxicity of cinnamic acid and related compounds
Lee et al. Essential oils in broiler nutrition
EP2292224B1 (en) Derivatives of lactiosole for preventing or treating diabetes
TWI245628B (en) Stabilized composition of reduced coenzyme Q10 aqueous solution
JP4440622B2 (en) Bad breath component cleaning composition and oral composition containing the same, chewing gum and refreshing confectionery in mouth
KR101614963B1 (en) Deodorant composition effective under weakly acidic conditions
WO1998044959A1 (en) Deodorant
EP0144417B1 (en) Composition of matter containing cinnamaldehyde and parabens
WO2006032668A1 (en) Use of aroma substance mixtures as agents against bad breath
US20220323372A1 (en) Composition for improving liver function
Parkash et al. Metabolism and excretion of [14C] furfural in the rat and mouse
JP5447392B2 (en) Chewing gum composition
JP4336272B2 (en) Tobacco odor deodorant, food and drink containing the same, deodorant composition, production method and use thereof
JP5742634B2 (en) New hydroxystilbene derivatives
Würsch et al. Metabolism of L-sorbose in the rat and the effect of the intestinal microflora on its utilization both in the rat and in the human
McGinty et al. Fragrance materials review on isoamyl alcohol
JP5742589B2 (en) New hydroxystilbene derivatives
AU718850B2 (en) Deodorizing substance
JPH0538358A (en) Deodorant
WO2000064453A1 (en) Intestinal fermentation sulfide deodorizers
JP2012111735A (en) New resveratrol derivative
JPH04117326A (en) Oral deodorizer
JP2013071930A (en) New hydroxystilbene derivative
US20230263762A1 (en) Composition and method for treating infections
US20040052828A1 (en) Consumable product including consumable component and alpha-keto enamine derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 2000572575

Format of ref document f/p: F